TRLV
Trulieve Cannabis Corp.
$8.40
+0.07
(+0.84%)
Mkt Cap
1.42B
Volume
61,374
52W Range
4.19-13.28
Sector
Healthcare
Beta
1.66
EPS (TTM)
-0.42
P/E Ratio
-14.25
Revenue (TTM)
1.17B
Rev Growth (5Y)
N/A
EPS Growth (5Y)
N/A
Company Description
Trulieve Cannabis Corp. engages in the cultivation, processing, manufacturing, and retail distribution of medical and adult-use cannabis products. It cultivates and produces its products in-house and distributes to its branded stores, as well as directly to patients via home delivery. The company was founded by Kim Rivers & Jason Pernell on September 17, 1940 and is headquartered in Tallahassee, FL.
Track Record
Showing latest 4 periods • Swipe for more
| Metric | 2025 |
|---|---|
| Revenue | 1.18B |
| Net Income | (116.38M) |
| EPS | -0.61 |
| Free Cash Flow | 212.31M |
| FCF / Share | 1.11 |
| Operating CF | 272.82M |
| Total Assets | 2.70B |
| Total Debt | 563.62M |
| Cash & Equiv | 255.53M |
| Book Value | 1.16B |
| Return on Equity | -0.10 |
| Metric | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 |
|---|---|---|---|---|
| Revenue | 286.75M | 293.15M | 288.19M | 302.09M |
| Net Income | 2.41M | (42.90M) | (26.84M) | (13.78M) |
| EPS | 0.01 | -0.22 | -0.14 | -0.07 |
| Free Cash Flow | 42.22M | 52.23M | 60.26M | 69.48M |
| FCF / Share | 0.22 | 0.27 | 0.32 | 0.36 |
| Operating CF | 55.71M | 59.22M | 76.77M | 85.70M |
| Total Assets | 2.78B | 2.70B | 2.94B | 2.92B |
| Total Debt | 628.70M | 563.62M | 813.06M | 823.70M |
| Cash & Equiv | 352.88M | 255.53M | 449.20M | 392.58M |
| Book Value | 1.17B | 1.16B | 1.20B | 1.23B |
| Return on Equity | 0.00 | -0.04 | -0.02 | -0.01 |
TRLV News
3 Top Marijuana Stocks That Can Make a Profitable Difference
Trulieve to Open Medical Cannabis Dispensary in Marco Island, Florida
Trulieve Cannabis Corp. to Hold Second Quarter 2026 Results Conference Call on August 7, 2026
Trulieve Named to TIME's America's Best Companies 2026 List
Better Cannabis Growth Stock: Trulieve or Vireo Growth
Trulieve Commemorates Georgia Medical Cannabis Launch with First Sale
Trulieve CEO Sells $1.2 Million in Stock as Shares Jump 148% in One Year
Trulieve Announces Planned Termination of Executive Automatic Securities Disposition Plan
Trulieve's NYSE Listing Is Historic. But Is the Stock Still Worth Buying?
The Marijuana Industry Just Had a Massive Milestone